Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the early access launch of ...

For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

Researchers from Radboud university medical center and University of Basel have discovered new genetic causes of inherited ...

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...

Experts explore HER2 mutations and the critical role of comprehensive molecular profiling in optimizing treatment for ...

Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments for rare conditions by using the agency’s “plausible mechanism” pathway.

When most people think about cancer, they think of bad luck, lifestyle choices, or something that “just happens.” Very few ...

About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...

Experts discuss the underutilization of biomarker testing in metastatic lung cancer, emphasizing the need for improved ...

Researchers used a panel to assess the presence of circulating tumor DNA in plasma samples and detected changes in genes related to the development of adenocarcinoma that indicated both actionability ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...